Title of Invention

ORAL CONTROLLED RELEASE FORMULATIONS

Abstract Pharnlaceutical composition comprising a core containing Rivastigmine as a pharmaceutically active agent and coating comprising an inner film and an outer film, wherein the inner film comprises cellulose acetate and is pernleable to water and body fluids and hinders egress of the dissolved Rivastigmine out of the core, and the outer film comprises ethylcellulose and is pernleable to water and body fluids.
Full Text

Documents:

in-pct-2002-425-che abstract.pdf

in-pct-2002-425-che claims granted.pdf

in-pct-2002-425-che correspondence others.pdf

in-pct-2002-425-che correspondence po.pdf

in-pct-2002-425-che description (complete) granted.pdf

in-pct-2002-425-che form 1.pdf

in-pct-2002-425-che form 19.pdf

in-pct-2002-425-che form 3.pdf

in-pct-2002-425-che form 5.pdf

in-pct-2002-425-che pct.pdf

in-pct-2002-425-che petition.pdf

in-pct-2002-425-che power of attorney.pdf


Patent Number 234121
Indian Patent Application Number IN/PCT/2002/425/CHE
PG Journal Number 22/2009
Publication Date 29-May-2009
Grant Date 06-May-2009
Date of Filing 20-Mar-2002
Name of Patentee NOVARTIS AG
Applicant Address SCHWARZWALDALLEE 215, CH-4058, BASEL,
Inventors:
# Inventor's Name Inventor's Address
1 SHAH RAJEN 4/12 KUMAR CITY, VADGAON HERI, OFF NAGAR ROAD, PUNE 411 014,
2 KHANNA SATISH CHANDRA SPITZACKERSTRASSE 6, CH-4103 BOTTMINGEN,
3 KALB OSKAR BELCHENSTRASSE 19/3, 79539 LORRACH,
4 OGORKA JORG IM STEINBRUNNEN 19/3, 79585 STEINEN,
PCT International Classification Number A61K 9/22
PCT International Application Number PCT/EP00/09455
PCT International Filing date 2000-09-27
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 9923045.0 1999-09-29 U.K.